Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
Plos One
|
December 25, 2015
Baseline Serum Osteopontin Levels Predict the Clinical Effectiveness of Tocilizumab but Not Infliximab in Biologic-Naïve Patients with Rheumatoid Arthritis: A Single-Center Prospective Study at 1 Year (the Keio First-Bio Cohort Study)
Keisuke Izumi, Yuko Kaneko, Misato Hashizume, et al.
Arthritis Research & Therapy
|
January 22, 2015
Peripheral blood CD4(+)CD25(+)CD127(low) regulatory T cells are significantly increased by tocilizumab treatment in patients with rheumatoid arthritis: increase in regulatory T cells correlates with clinical response
Jun Kikuchi, Misato Hashizume, Yuko Kaneko, et al.
Journal of Translational Medicine
|
June 9, 2018
Discriminating phenotypic signatures identified for tocilizumab, adalimumab, and tofacitinib monotherapy and their combinations with methotrexate
Alison O'Mahony, Markus R John, Hannah Cho, et al.
Clinical and Experimental Immunology
|
September 14, 2013
Anti-interleukin-6 receptor antibody prevents systemic bone mass loss via reducing the number of osteoclast precursors in bone marrow in a collagen-induced arthritis model
Keisuke Tanaka, Misato Hashizume, Masahiko Mihara, et al.
Arthritis Research & Therapy
|
May 2, 2012
Interleukin-6 regulates anti-arthritic effect of methotrexate via reduction of SLC19A1 expression in a mouse arthritis model
Misato Hashizume, Hiroto Yoshida, Keisuke Tanaka, et al.
Antimicrobial Agents and Chemotherapy
|
April 28, 2010
Striking species difference in the contribution of concentrative nucleoside transporter 2 to nucleoside uptake between mouse and rat hepatocytes
Tomomi Furihata, Yukina Fukuchi, Minami Iikura, et al.
Nature Reviews. Rheumatology
|
April 25, 2020
Translating IL-6 biology into effective treatments
Ernest H Choy, Fabrizio De Benedetti, Tsutomu Takeuchi, et al.
International Reviews of Immunology
|
August 8, 2014
Tocilizumab, a humanized anti-IL-6R antibody, as an emerging therapeutic option for rheumatoid arthritis: molecular and cellular mechanistic insights
Misato Hashizume, Seng-Lai Tan, Junichi Takano, et al.
Modern Rheumatology
|
October 21, 2025
Effectiveness and safety of tocilizumab, an anti-interleukin-6 receptor antibody, in 342 Japanese patients with multicentric Castleman disease: a 3-year, prospective, observational study
Norihiro Nishimoto, Miho Murakami, Takeshi Johkoh, et al.
JCI Insight
|
July 21, 2017
Host interleukin 6 production regulates inflammation but not tryptophan metabolism in the brain during murine GVHD
Ludovic Belle, Vivian Zhou, Kara L Stuhr, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
Plos One
|
December 25, 2015
Baseline Serum Osteopontin Levels Predict the Clinical Effectiveness of Tocilizumab but Not Infliximab in Biologic-Naïve Patients with Rheumatoid Arthritis: A Single-Center Prospective Study at 1 Year (the Keio First-Bio Cohort Study)
Keisuke Izumi, Yuko Kaneko, Misato Hashizume, et al.
Arthritis Research & Therapy
|
January 22, 2015
Peripheral blood CD4(+)CD25(+)CD127(low) regulatory T cells are significantly increased by tocilizumab treatment in patients with rheumatoid arthritis: increase in regulatory T cells correlates with clinical response
Jun Kikuchi, Misato Hashizume, Yuko Kaneko, et al.
Journal of Translational Medicine
|
June 9, 2018
Discriminating phenotypic signatures identified for tocilizumab, adalimumab, and tofacitinib monotherapy and their combinations with methotrexate
Alison O'Mahony, Markus R John, Hannah Cho, et al.
Clinical and Experimental Immunology
|
September 14, 2013
Anti-interleukin-6 receptor antibody prevents systemic bone mass loss via reducing the number of osteoclast precursors in bone marrow in a collagen-induced arthritis model
Keisuke Tanaka, Misato Hashizume, Masahiko Mihara, et al.
Arthritis Research & Therapy
|
May 2, 2012
Interleukin-6 regulates anti-arthritic effect of methotrexate via reduction of SLC19A1 expression in a mouse arthritis model
Misato Hashizume, Hiroto Yoshida, Keisuke Tanaka, et al.
Antimicrobial Agents and Chemotherapy
|
April 28, 2010
Striking species difference in the contribution of concentrative nucleoside transporter 2 to nucleoside uptake between mouse and rat hepatocytes
Tomomi Furihata, Yukina Fukuchi, Minami Iikura, et al.
Nature Reviews. Rheumatology
|
April 25, 2020
Translating IL-6 biology into effective treatments
Ernest H Choy, Fabrizio De Benedetti, Tsutomu Takeuchi, et al.
International Reviews of Immunology
|
August 8, 2014
Tocilizumab, a humanized anti-IL-6R antibody, as an emerging therapeutic option for rheumatoid arthritis: molecular and cellular mechanistic insights
Misato Hashizume, Seng-Lai Tan, Junichi Takano, et al.
Modern Rheumatology
|
October 21, 2025
Effectiveness and safety of tocilizumab, an anti-interleukin-6 receptor antibody, in 342 Japanese patients with multicentric Castleman disease: a 3-year, prospective, observational study
Norihiro Nishimoto, Miho Murakami, Takeshi Johkoh, et al.
JCI Insight
|
July 21, 2017
Host interleukin 6 production regulates inflammation but not tryptophan metabolism in the brain during murine GVHD
Ludovic Belle, Vivian Zhou, Kara L Stuhr, et al.
Page
of 4